Association Between Loss of Dp140 and Cognitive Impairment in Duchenne and Becker Dystrophies
By: T Chamova, V Guergueltcheva, M Raycheva, T Todorov, J Genova, S Bichev, V Bojinova, V Mitev, I Tournev and A Todorova
Open Access
|Oct 2013References
- 1. Griggs RC, Bushby K. Continued need for caution in the diagnosis of Duchenne muscular dystrophy. Neurology. 2005; 64(10): 1498-1499.
- 2. Barnea E, Zuk D, Simantov R, Nudel U, Yaffe D. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron. 1990; 5(6): 881-888.
- 3. Boyce FM, Beggs AH, Feener C, Kunkel LM. Dys-trophin is transcribed in brain from a distant upstream promoter. Proc Natl Acad Sci USA. 1991; 88(4): 1276-1280.
- 4. Gorecki DC, Monaco AP, Derry JMJ, Walker AP, Barnard AE, Barnard PJ. Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum Mol Genet. 1992; 1(7): 505-510.
- 5. Hugnot JP, Gilgenkrantz H, Vincent N, Chafey P, Morris GE, Monaco AP,Distal transcript of the dystrophin gene initiated from an alternative first exon and encoding a 75-kDa protein widely distributed in non muscle tissues. Proc Natl Acad Sci USA. 1992; 89(16): 7506-7510.
- 6. Lederfein D, Levy Z, Augier N, Mornet D, Morris G, Fuchs O,A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci USA. 1992; 89(12): 5346-5350.
- 7. Rapaport D, Passos-Bueno MR, Takata RI, Campiotto S, Eggers S, Vainzof M,A deletion including the brain promoter of the Duchenne muscular dystrophy gene is not associated with mental retardation. Neuromusc Disord. 1992; 2(2): 117-120.
- 8. Byers TJ, Lidov HGW, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993; 4(1): 77-81.
- 9. Pereira CC, Kiyomoto BH, Cardoso R, Oliveira AS. Duchenne muscular dystrophy, α-dystroglycan immuno-expression in skeletal muscle and cognitive performance. Arq Neuropsiquiatr. 2005; 63(4): 984-989.
- 10. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP,N. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy Neurology. 2000; 55(4): 559-564.
- 11. Billard C, Gillet P, Signoret JL, Uicaut E, Bertrand P, Fardeau M,Cognitive functions in Duchenne muscular dystrophy: A reappraisal and comparison with spinal muscular atrophy. Neuromusc Disord. 1992; 2(5-6): 371-378.
- 12. Moizard M, Billard C, Toutain A, Berret F, Marmin N, Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998; 80(1): 32-41.
- 13. Cotton S, Voudouris NJ, Greenwood KM. Intel-ligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001; 43(7): 497-501.
- 14. Schneider SC, Tan G. Attention-deficit hyperactivity disorder. In pursuit of diagnostic accuracy. Postgrad Med. 1997; 101(4): 231-232.
- 15. Bardoni A, Sironi M, Felisari G, Comi GP, Bresolin N. Absence of brain Dp140 isoform and cognitive impairment in Becker muscular dystrophy. Lancet 1999; 353(9156): 897-898.
- 16. Young HK, Barton BA, Waisbren S, Dale LP, Ryan MM, Webster RI,Cognitive and psychological profile of males with Becker muscular dystrophy. J Child Neurol. 2008; 23(2): 155-162.
- 17. D’Angelo MG, Bresolin N. Cognitive impairment in neuromuscular disorders. Muscle Nerve. 2006; 34(1): 16-33.
- 18. Bardoni A, Felisari G, Sironi M, Comi G, Lai M, Robotti M,Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromusc Dis. 2000; 10(3): 194-199.
- 19. Lidov HGW, Selg S, Kunkel LM. Dp140: a novel 140 KDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995; 4(3): 329-335.
- 20. Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR,Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS ONE 2010; 5(1): 1-9.
- 21. Bhat S, Schmidt K, Ladd S, Kim K, Schwartz C, Simensen RJ,Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenet Genome Res. 2006; 112(1-2): 170-175.
- 22. Moizard M, Toutain A, Fournier D, Berret F, Raynaud M, Billard C,Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 2000; 8(7): 552-556.
- 23. Anderson JL, Head SI, Rae C, Morely JW. Brain function in Duchenne muscular dystrophy. Brain. 2002; 125(Pt 1): 4-13.
- 24. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B,Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011; 18(1): 90-95.
- 25. D’Angelo MG, Lorusso, Civati F, Comi GP, Magri F, Del Bo R,Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011; 45(5): 292-299.
DOI: https://doi.org/10.2478/bjmg-2013-0014 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 21 - 29
Published on: Oct 3, 2013
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2013 T Chamova, V Guergueltcheva, M Raycheva, T Todorov, J Genova, S Bichev, V Bojinova, V Mitev, I Tournev, A Todorova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.